<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
  <id>https://recalls.watch/feed/substance-pitavastatin.xml</id>
  <title>Recalls Watch: Pitavastatin</title>
  <link rel="self" href="https://recalls.watch/feed/substance-pitavastatin.xml"/>
  <link href="https://recalls.watch/alerts/"/>
  <updated>2026-03-25T00:00:00Z</updated>
  <entry>
    <id>https://recalls.watch/recall/fda/98543/</id>
    <title>Annora Pharma Private Limited: Pitavastatin Tablets</title>
    <link href="https://recalls.watch/recall/fda/98543/"/>
    <updated>2026-03-25T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Presence of foreign tablets/capsules: one Pitavastatin tablet 1mg found in bottle of Pitavastatin tablets 2mg</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/97160/</id>
    <title>AvKARE: Pitavastatin Tablets and 1 more</title>
    <link href="https://recalls.watch/recall/fda/97160/"/>
    <updated>2025-07-09T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Failed Impurity/Degradation Specifications</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/97076/</id>
    <title>Orient Pharma Co., Ltd. Yunlin Plant: Pitavastatin Tablets and 1 more</title>
    <link href="https://recalls.watch/recall/fda/97076/"/>
    <updated>2025-07-09T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Failed Impurities/Degradation Specifications.</summary>
  </entry>
</feed>
